Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 16, 2024

BUY
$0.15 - $0.34 $15 - $34
100 New
100 $0
Q2 2022

Oct 27, 2022

SELL
$2.53 - $4.42 $349 - $609
-138 Reduced 57.98%
100 $0
Q2 2022

Aug 15, 2022

SELL
$2.53 - $4.42 $349 - $609
-138 Reduced 57.98%
100 $0
Q1 2022

Oct 27, 2022

BUY
$3.78 - $4.66 $521 - $643
138 Added 138.0%
238 $1,000
Q1 2022

May 13, 2022

BUY
$3.78 - $4.66 $264 - $326
70 Added 41.67%
238 $1,000
Q4 2021

Feb 14, 2022

SELL
$4.12 - $6.35 $102,093 - $157,353
-24,780 Reduced 99.33%
168 $1,000
Q3 2021

Nov 15, 2021

BUY
$5.76 - $9.95 $143,700 - $248,232
24,948 New
24,948 $150,000

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.